Vitalivas Vitaliv

Thursday, October 8, 2015

Google Alert - "anti diabetes"

Google
"anti diabetes"
As-it-happens update October 8, 2015
WEB
US drug maker Merck wins Anti-diabetes Patent against Indian competitor Glenmark
Merck sells the medicine to control type-2 diabetes under the brands of Januvia and Janumet. It also licenses the use of its patent to Sun ...
Google Plus Facebook Twitter Flag as irrelevant
HC restrain Glenmark from selling anti-diabetes drugs
HC restrain Glenmark from selling anti-diabetes drugs. New Delhi, Oct 7 (IANS) The Delhi High Court on Wednesday restrained Mumbai-based ...
Google Plus Facebook Twitter Flag as irrelevant
Anti-diabetes Drug
US drug maker Merck wins Anti-diabetes Patent against Indian competitor Glenmark. The Delhi High Court on Wednesday, October 07, 2015 in a ...
Google Plus Facebook Twitter Flag as irrelevant
High Court restrains Glenmark Pharmaceuticals from business of anti-diabetes drugs
Hindustan TimesHigh Court restrains Glenmark Pharmaceuticals from business of anti-diabetes drugsEconomic TimesNEW DELHI: In a relief for US ...
Google Plus Facebook Twitter Flag as irrelevant
HC restrains Glenmark from selling anti-diabetes drugs Zita, Zita-Met
In a relief for U.S. drug major Merck Sharp and Dohme, the Delhi High Court on Wednesday restrained Indian firm Glenmark Pharmaceuticals from …
Google Plus Facebook Twitter Flag as irrelevant
Delhi HC restrains Glenmark Pharmaceuticals from selling anti
TheDelhi High Court on Wednesday restrainedGlenmark Pharmaceuticalsfrom manufacturing and selling anti- diabetes drugs. Further details ...
Google Plus Facebook Twitter Flag as irrelevant
Freestyle Test Strips Diabetes
Post Gestational Diabetes Anti Diabetes Tablets Further analysis showed that greater reduction in risk of developing diabetes was observed for ...
Google Plus Facebook Twitter Flag as irrelevant
HC restrain Glenmark from selling anti-diabetes drugs
HC restrain Glenmark from selling anti-diabetes drugs. Posted, 2015-10-07. Yahoo Daily News. SMS this page; Email this page. New Delhi, Oct 7 ...
Google Plus Facebook Twitter Flag as irrelevant
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Vitalivas Vitaliv